Tu1373 WHAT IS THE NEXT TREATMENT OPTION FOR PATIENT REFRACTORY TO RABEPRAZOLE 5 MG IN RELATION TO CYP2C19 GENOTYPE STATUS?
Murata, Masaki, Sugimoto, MitsushigeVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)33376-x
Date:
May, 2020
File:
PDF, 292 KB
2020